Parallel changes in the blood levels of abnormally-fucosylated haptoglobin and alpha 1,3 fucosyltransferase in relationship to tumour burden: more evidence for a disturbance of fucose metabolism in cancer
- 1 August 1992
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 65 (2), 115-121
- https://doi.org/10.1016/0304-3835(92)90154-n
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasisBritish Journal of Cancer, 1991
- Decreased fucose incorporation in cell surface carbohydrates is associated with inhibition of invasionClinical & Experimental Metastasis, 1989
- Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate AntigensAdvances in Cancer Research, 1989
- Cancer-associated elevation of α(1 → 3)-l-fucosyltransferase activity in human serumCancer, 1988
- Inhibition of metastatic potential by fucosidase: An NMR study identifies a cell surface metastasis markerJournal of Cellular Biochemistry, 1988
- Elevated levels of abnormally-fucosylated haptoglobins in cancer seraBritish Journal of Cancer, 1987
- A simple, reproducible and cheap batch method for the analysis of serum glycoproteins using Sepharose-coupled lectins and silver stainingClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- Use of N-acetyl-2′-O-methyllactosamine as a specific acceptor for the determination of α-l-(1→3)-fucosyltransferase in human serumAnalytical Biochemistry, 1986
- Evaluation of two plasma fucosyltransferases as marker enzymes in non-Hodgkin's lymphomaCancer, 1978
- Glycosyltransferase Levels in Tumors Metastatic to Liver and in Uninvolved Liver Tissue 2JNCI Journal of the National Cancer Institute, 1977